My. Min et al., Synaptically released glutamate reduces gamma-aminobutyric acid (GABA)ergic inhibition in the hippocampus via kainate receptors, P NAS US, 96(17), 1999, pp. 9932-9937
Citations number
38
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Exogenous application of agonists at the kainate subtype of glutamate recep
tors has been shown to depress evoked monosynaptic inhibition by gamma-amin
obutyric acid (GABA)ergic interneurons in the hippocampus, This observation
has led to the hypothesis that synaptic release of endogenous glutamate mi
ght have a disinhibitory effect on neuronal circuits, in addition to depola
rizing neurons via postsynaptic alpha-amino-3-hydroxy-5-methyl-4-isoriazole
propionic acid (AMPA), kainate, and N-methyl-D-aspartic acid (NMDA) recepto
rs, It is not known, however, if glutamate released from excitatory neurons
has the same kainate receptor-mediated effect on monosynaptic inhibitory t
ransmission as exogenous agonist application. Indeed, the recent demonstrat
ion that excitatory synaptic signals elicited in interneurons are partly me
diated by kainate receptors suggests that these receptors may have a pro- r
ather than disinhibitory role. Here, we examine the effect of synaptically
released glutamate on monosynaptic inhibitory signaling, In the presence of
antagonists to AMPA and NMDA receptors, brief bursts of activity in glutam
atergic afferent fibers reduce GABAergic transmission. This depression of i
nhibition is reversibly abolished by blocking kainate receptors, It persist
s when GABA(B) receptors are blocked and is enhanced by blocking metabotrop
ic glutamate receptors, possibly explained by presynaptic regulation of glu
tamate release from excitatory afferents by metabotropic autoreceptors. We
conclude that the net kainate receptor-mediated effect of synaptically rele
ased glutamate is to reduce monosynaptic inhibition. Since this form of dis
inhibition may contribute to seizure initiation, kainate receptors may cons
titute an important target for anticonvulsant drug development.